FERRARI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.613
EU - Europa 7.559
AS - Asia 5.693
SA - Sud America 865
AF - Africa 149
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 27.900
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.377
IT - Italia 2.064
GB - Regno Unito 2.031
SG - Singapore 1.719
CN - Cina 1.550
DE - Germania 891
VN - Vietnam 770
BR - Brasile 689
SE - Svezia 627
HK - Hong Kong 506
FR - Francia 439
RU - Federazione Russa 293
FI - Finlandia 263
UA - Ucraina 261
BD - Bangladesh 213
PL - Polonia 198
TR - Turchia 187
KR - Corea 161
IN - India 160
CA - Canada 128
BG - Bulgaria 93
NL - Olanda 79
JP - Giappone 66
MX - Messico 63
ID - Indonesia 62
IQ - Iraq 60
AR - Argentina 59
ZA - Sudafrica 50
BE - Belgio 45
IE - Irlanda 41
ES - Italia 40
AE - Emirati Arabi Uniti 35
CH - Svizzera 34
LT - Lituania 32
PK - Pakistan 31
AT - Austria 29
CL - Cile 23
SA - Arabia Saudita 23
EC - Ecuador 21
UZ - Uzbekistan 21
MA - Marocco 19
CO - Colombia 18
MY - Malesia 18
PH - Filippine 16
VE - Venezuela 16
CZ - Repubblica Ceca 15
PY - Paraguay 15
DZ - Algeria 14
EG - Egitto 14
PT - Portogallo 14
AZ - Azerbaigian 12
JO - Giordania 12
DK - Danimarca 11
ET - Etiopia 11
IR - Iran 11
KE - Kenya 11
HU - Ungheria 10
PE - Perù 10
TN - Tunisia 10
BO - Bolivia 8
BY - Bielorussia 8
AU - Australia 7
BH - Bahrain 7
EU - Europa 7
JM - Giamaica 7
AL - Albania 6
DO - Repubblica Dominicana 6
RO - Romania 6
SN - Senegal 6
TW - Taiwan 6
UY - Uruguay 6
GT - Guatemala 5
KZ - Kazakistan 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
GR - Grecia 4
HN - Honduras 4
LV - Lettonia 4
MD - Moldavia 4
NI - Nicaragua 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
TZ - Tanzania 4
GD - Grenada 3
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
Totale 27.869
Salva come PNG Salva come JPEG
Città #
Southend 1.466
Ashburn 1.402
Fairfield 1.294
Santa Clara 1.114
Singapore 1.055
Woodbridge 890
Chandler 753
Houston 601
Seattle 527
Ann Arbor 512
San Jose 508
Hong Kong 494
Cambridge 468
Jacksonville 468
Dearborn 458
Wilmington 444
Hefei 392
Frankfurt am Main 389
Nyköping 363
Beijing 285
Modena 276
London 241
Ho Chi Minh City 224
Council Bluffs 196
New York 189
Los Angeles 186
Hanoi 185
Helsinki 161
Seoul 146
Kraków 145
Milan 128
The Dalles 122
Chicago 109
Princeton 98
San Diego 92
Sofia 92
Izmir 91
Munich 89
Eugene 87
Moscow 84
Shanghai 84
Lauterbourg 82
Fremont 76
Orem 74
Redwood City 69
São Paulo 68
Buffalo 64
Rome 60
Boardman 59
Bologna 55
Porto Alegre 54
Tokyo 49
Bremen 46
Da Nang 42
Warsaw 42
Salt Lake City 41
Brussels 40
Dallas 40
Dublin 40
Brooklyn 36
Naples 36
Des Moines 35
Guangzhou 32
Chennai 31
Jakarta 31
Verona 31
Denver 30
Grafing 30
Atlanta 29
Falls Church 28
Phoenix 28
Ottawa 27
Stockholm 27
Toronto 27
Haiphong 26
Montreal 26
Turku 26
Baghdad 25
Belo Horizonte 23
Cape Town 23
Columbus 23
Parma 23
Amsterdam 22
Norwalk 22
Elk Grove Village 21
Marseille 19
Mumbai 19
Poplar 19
Tampa 19
Paris 18
San Francisco 18
Florence 17
Manchester 17
Mexico City 17
Reggio Emilia 17
Biên Hòa 16
Dhaka 16
Dong Ket 16
Milwaukee 16
Tashkent 16
Totale 18.887
Salva come PNG Salva come JPEG
Nome #
STRUTTURA DEL CRISTALLO DEL COMPLESSO DI TIMIDILATO SINTETASI (TS) CON UN LIGANDO 828
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 486
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 461
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes 436
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 435
Metodo per la funzionalizzazione sito specifica di molecole proteiche 430
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 429
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 427
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 426
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections 418
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 414
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 409
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 408
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 401
Antibacterial agent discovery using thymidylate synthase biolibrary screening 393
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 385
Biochemistry: Anchors away 385
2′-Deoxyuridine 5′-Monophosphate Substrate Displacement in Thymidylate Synthase through 6-Hydroxy-2H-naphtho[1,8-bc]furan-2-one Derivatives 371
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 370
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 363
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 362
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs 359
Allosteric Inhibition of human Thymidylate Synthase. 357
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 356
Structure-Based Selectivity Optimization of Piperidine–Pteridine Derivatives as Potent Leishmania Pteridine Reductase Inhibitors 352
Thymidylate synthase structure, function and implication in drug discovery 351
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment 351
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer 347
Crystal Structure of human thymidylate synthase bound to a peptide inhibitor 343
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 343
A proteomic approach to investigate the mechanism of action of anticancer peptides 342
NUOVE MOLECOLE, PER USO COME AGENTI ANTITUMORALI 342
Current and Future Chemotherapy for Chagas Disease 342
Crystal Structure of histidine-tagged human thymidylate synthase 340
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding 337
Development of flavonoids derivatives as leads against Leishmaniasis and Trypanosomiasis-invited lecture 336
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 329
ANTICANCER DRUGS 328
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To InhibitTrypanosoma bruceiPteridine Reductase in Support of Early-Stage Drug Discovery 325
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 322
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 321
Hotspots in an obligate homodimeric anticancer target. structural and functional effects of interfacial mutations in human thymidylate synthase 321
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 319
Biochemical effects of riluzole on Leishmania parasites 315
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors 312
Homodimeric Enzymes as Drug Targets 311
Alternative strategies in medicinal chemistry to face drug resistance in anticancer therapy. 311
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 309
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 302
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent 296
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 295
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 293
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 293
Protein-protein interaction inhibitors: case studies on Small Molecules and Natural Compounds. 291
Identification of the binding modes of N-phenylphthalimides inhibiting bacterial thymidylate synthase through X-ray crystallography screening 291
Targeting the trypanosomatidic enzymes pteridine reductase and dihydrofolate reductase. 289
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 286
Intrinsic Fluorescence of the Active and the Inactive Functional Forms of Human Thymidylate Synthase 286
Update on antifolate drugs targets 283
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 282
Zing meeting on Medicinal Chemistry 2012-Lanzarote-invitated lecture 282
Target-based approaches for the discovery of new antimycobacterial drugs 274
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 267
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 266
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 260
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 252
COMPOSTI AD ATTIVITÀ ANTIPARASSITARIA 249
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 245
The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition 245
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 242
Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities 234
Interfering with Human Thymidylate Synthase Dimerization against ovarian human carcinoma 225
Congress on - Medicinal Chemistry in parasitology: new avenues in drug discovery-organised in Modena in 2007. 224
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 224
Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development. 220
Interfering with Human Thymidylate Synthase Dimerization anti peptide design in the search of anticancer agents against ovarian human carcinoma 220
Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections 211
Compounds having antiparasitic activity 210
Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents 206
Ovarian Cancer Drug Resistance 204
Inhibitor Specificity via Protein Dynamics. Insights from the Design of Antibacterial Agents Targeted Against Thymidylate Synthase 201
The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism 197
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 193
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 189
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 174
From ligand-based design to Hit validation of new thymidylate synthase inhibitors 173
Medicinal chemistry in parasitology 169
International Congress.Drug resistance in ovarian cancer:bomarkers andtreatments. 167
Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family 155
Laboratory of reference for trypanosomatidic infections -In-Vitro-and-In-Vivo-Screenings-of-New-Antiparasitic-Compounds-State-of-the-art-and-New-Developments-COST B22 136
European COST B22 Lab for antiparasitic drug screening (http://www.icp.ucl.ac.be/cost/costB22/ screening_survey.pdf )-2008-2012. 130
Totale 28.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.302
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 0 0 0 0 0 0 123
2021/20222.086 92 189 184 103 81 213 98 140 227 134 404 221
2022/20232.254 243 282 162 226 220 309 52 212 236 50 134 128
2023/20241.800 54 92 114 128 608 184 95 153 69 38 109 156
2024/20254.190 191 60 134 274 817 538 325 230 401 162 474 584
2025/20267.945 456 309 563 906 1.222 557 1.036 388 834 794 455 425
Totale 28.189